Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
In Vitro Diagnostics

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1785860

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1785860

Blood Testing

PUBLISHED:
PAGES: 206 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Blood Testing Market to Reach US$143.1 Billion by 2030

The global market for Blood Testing estimated at US$93.3 Billion in the year 2024, is expected to reach US$143.1 Billion by 2030, growing at a CAGR of 7.4% over the analysis period 2024-2030. Glucose Testing, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$26.2 Billion by the end of the analysis period. Growth in the A1C Testing segment is estimated at 6.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$25.4 Billion While China is Forecast to Grow at 11.4% CAGR

The Blood Testing market in the U.S. is estimated at US$25.4 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$29.9 Billion by the year 2030 trailing a CAGR of 11.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.8% and 7.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.9% CAGR.

Global Blood Testing Market - Key Trends & Drivers Summarized

Why Is Blood Testing Becoming More Essential in Modern Healthcare?

Blood testing is one of the most fundamental diagnostic procedures in healthcare, providing critical insights into a patient’s overall health, disease status, and treatment response. From routine screenings to complex biomarker analysis, blood tests are used for diagnosing infections, metabolic disorders, cardiovascular diseases, cancers, and autoimmune conditions. The increasing prevalence of chronic diseases, rising awareness of preventive healthcare, and advancements in diagnostic technology have fueled the demand for blood testing in hospitals, diagnostic laboratories, and point-of-care settings.

The COVID-19 pandemic further highlighted the importance of rapid and accurate blood testing, leading to increased investments in diagnostic infrastructure and the adoption of advanced technologies, such as PCR-based and serological tests. Additionally, personalized medicine and precision diagnostics have expanded the role of blood testing in guiding targeted therapies, particularly in oncology and genetic disorders. As healthcare systems continue to shift toward early disease detection and preventive care, the demand for fast, accurate, and minimally invasive blood testing solutions is expected to rise significantly.

How Are Technological Advancements Transforming Blood Testing?

Significant innovations in blood testing technology are enhancing accuracy, speed, and convenience, making diagnostics more accessible to patients and healthcare providers. One of the most transformative advancements in this field is the development of liquid biopsy technology, which enables the detection of cancer and other diseases through circulating tumor DNA (ctDNA) and biomarkers in the blood. Liquid biopsies offer a non-invasive alternative to traditional tissue biopsies, allowing for early cancer detection, disease monitoring, and treatment response evaluation.

Another breakthrough in blood testing is the emergence of point-of-care (POC) and home-based blood testing devices. These portable and user-friendly systems enable rapid testing for glucose, cholesterol, infectious diseases, and coagulation levels without requiring a full laboratory setup. Additionally, artificial intelligence (AI) and machine learning (ML) are being integrated into diagnostic platforms to enhance test interpretation, improve predictive analytics, and reduce diagnostic errors. The adoption of microfluidic and lab-on-a-chip technologies has also streamlined sample processing, enabling rapid and automated blood analysis with minimal sample volumes. As these technological advancements continue to evolve, they are revolutionizing the blood testing landscape, making diagnostics faster, more precise, and increasingly patient-centric.

Which Market Trends Are Driving Growth in the Blood Testing Industry?

The growing emphasis on preventive healthcare and routine screening is one of the most influential trends driving the blood testing market. With a rise in lifestyle-related conditions such as diabetes, cardiovascular diseases, and liver disorders, more individuals are undergoing regular blood tests for early detection and risk assessment. The increasing availability of direct-to-consumer (DTC) blood testing services, where individuals can order tests online without a physician’s referral, is also fueling market expansion. These services offer at-home sample collection and digital result interpretation, providing greater convenience and accessibility for health-conscious consumers.

Another key trend shaping the market is the expansion of genetic and biomarker-based blood tests. As precision medicine gains traction, blood testing is being used to identify genetic predispositions to diseases, guide targeted treatments, and monitor disease progression. Additionally, the rise of telemedicine and remote patient monitoring has accelerated the adoption of connected blood testing devices that sync with digital health platforms, enabling real-time tracking and physician consultations. The growing global focus on infectious disease surveillance, including emerging threats such as antimicrobial resistance, is also driving demand for rapid and high-throughput blood testing solutions.

What Are the Key Growth Drivers Shaping the Future of the Blood Testing Market?

The growth in the blood testing market is driven by several critical factors, including rising disease prevalence, advancements in diagnostic technology, and increasing healthcare investments. One of the primary growth drivers is the rising incidence of chronic and infectious diseases, which has led to an increased need for early and accurate diagnosis. Governments and healthcare organizations worldwide are prioritizing disease prevention and early intervention, leading to greater adoption of routine blood testing for population health management.

Another crucial driver shaping the market is the increasing shift toward decentralized and at-home testing solutions. As consumers demand greater convenience and accessibility, diagnostic companies are investing in portable, user-friendly blood testing devices that provide rapid results without the need for laboratory visits. Additionally, advancements in data analytics and AI-driven diagnostics are enhancing test accuracy, enabling personalized risk assessments and predictive modeling for various diseases. As the global healthcare landscape continues to evolve, the blood testing market is expected to expand, driven by innovation, increasing health awareness, and the continuous pursuit of more efficient, cost-effective diagnostic solutions.

SCOPE OF STUDY:

The report analyzes the Blood Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Test Type (Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing, Thyroid-stimulating Hormone (TSH) Testing, Serum Nicotine/Cotinine Testing, High sensitivity CRP Testing, Testosterone Testing, ALT Testing, Cortisol Testing, Creatinine Testing, AST Testing, Others Blood Tests)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 47 Featured) -

  • Abbott Laboratories
  • ARUP Laboratories
  • Beckman Coulter
  • Becton, Dickinson and Company (BD)
  • Bio-Rad Laboratories
  • Cepheid
  • Charles River Laboratories
  • Eurofins Scientific
  • Genomic Health
  • Illumina
  • Labcorp (Laboratory Corp of America)
  • Myriad Genetics
  • Natera
  • PerkinElmer
  • Qiagen
  • Quest Diagnostics
  • Roche Diagnostics
  • Siemens Healthineers
  • Sonic Healthcare
  • Thermo Fisher Scientific

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Show more
Product Code: MCP29650

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Blood Testing - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Disease Burden Across Populations Throws the Spotlight on Preventive and Routine Blood Testing
    • Rising Demand for Early Diagnosis and Risk Stratification Propels Growth in Comprehensive Blood Testing Panels
    • Expansion of Point-of-Care Testing (POCT) Ecosystems Drives Decentralized Blood Testing Adoption
    • Technological Advancements in Microfluidics and Lab-on-Chip Devices Expand the Addressable Market for Rapid Testing Solutions
    • AI and Predictive Analytics Integration Strengthens the Business Case for Smart, Data-Driven Blood Diagnostics
    • Shift Toward Personalized and Precision Medicine Accelerates Demand for Biomarker-Based Blood Tests
    • Consumerization of Diagnostics Fuels Growth in At-Home Blood Testing Kits and Services
    • Proliferation of Telehealth Models Drives the Need for Seamless Remote Blood Testing Integration
    • Increased Utilization of Multiplex Testing Platforms Spurs Efficiency and Cost-Effectiveness in Labs
    • Growing Preference for Non-Invasive and Minimal Sample Volume Testing Sustains Demand for Capillary Blood Solutions
    • Public Health Initiatives and Screening Campaigns Generate Widespread Demand Across Demographic Segments
    • Rising Awareness of Lifestyle-Related Disorders Strengthens Market Uptake in Wellness and Preventive Health Sectors
    • Digital Health Integration and EHR Compatibility Propel Adoption of Connected Blood Testing Systems
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Blood Testing Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Blood Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Blood Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Blood Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Glucose Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Glucose Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Glucose Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for A1C Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for A1C Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for A1C Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Direct LDL Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Direct LDL Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Direct LDL Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Lipid Panel Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Lipid Panel Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Lipid Panel Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Prostate-specific Antigen Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Prostate-specific Antigen Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Prostate-specific Antigen Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for COVID-19 Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for COVID-19 Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for COVID-19 Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for BUN Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for BUN Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for BUN Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Vitamin-D Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Vitamin-D Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Vitamin-D Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Thyroid-stimulating Hormone by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Thyroid-stimulating Hormone by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Thyroid-stimulating Hormone by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Blood Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • JAPAN
    • Blood Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • CHINA
    • Blood Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • EUROPE
    • Blood Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Blood Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Blood Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Europe 15-Year Perspective for Blood Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • FRANCE
    • Blood Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 50: France Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: France Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: France 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • GERMANY
    • Blood Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 53: Germany Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Germany Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Germany 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 56: Italy Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Italy Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Italy 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Blood Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 59: UK Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: UK Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: UK 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 62: Spain Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Spain Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Spain 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 65: Russia Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Russia Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Russia 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 68: Rest of Europe Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Rest of Europe Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Rest of Europe 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Blood Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 71: Asia-Pacific Recent Past, Current & Future Analysis for Blood Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 72: Asia-Pacific Historic Review for Blood Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Asia-Pacific 15-Year Perspective for Blood Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 74: Asia-Pacific Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Asia-Pacific Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Asia-Pacific 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Blood Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 77: Australia Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Australia Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Australia 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • INDIA
    • Blood Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 80: India Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: India Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: India 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 83: South Korea Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: South Korea Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: South Korea 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 86: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Asia-Pacific Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Rest of Asia-Pacific 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Blood Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 89: Latin America Recent Past, Current & Future Analysis for Blood Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 90: Latin America Historic Review for Blood Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Latin America 15-Year Perspective for Blood Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 92: Latin America Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Latin America Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Latin America 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 95: Argentina Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Argentina Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Argentina 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 98: Brazil Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Brazil Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Brazil 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 101: Mexico Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Mexico Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Mexico 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 104: Rest of Latin America Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Latin America Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Rest of Latin America 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Blood Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 107: Middle East Recent Past, Current & Future Analysis for Blood Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 108: Middle East Historic Review for Blood Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Middle East 15-Year Perspective for Blood Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 110: Middle East Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Middle East Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Middle East 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 113: Iran Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Iran Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Iran 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 116: Israel Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Israel Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Israel 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 119: Saudi Arabia Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Saudi Arabia Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Saudi Arabia 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 122: UAE Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: UAE Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: UAE 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 125: Rest of Middle East Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Middle East Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Middle East 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • AFRICA
    • Blood Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 128: Africa Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Africa Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Africa 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!